You are here

Article Text

Article menu
Download PDFPDF
Economics
Early opportunistic screening was cost effective in young adults with type 2 diabetes

https://doi.org/10.1136/ebn.2.3.91

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Cdc Diabetes Cost-Effectiveness Study Group.The cost-effectiveness of screening for type 2 diabetes. JAMA1998 Nov 25;280:1757–63.OpenUrlCrossRefPubMedWeb of Science

    Question Is opportunistic screening for early detection and treatment of type 2 diabetes cost effective?

    Design

    Cost effectiveness analysis using a semi-Markov Monte Carlo simulation model.

    Setting

    A single payer healthcare system in the US.

    Patients

    A hypothetical cohort of people ≥25 years of age without clinically diagnosed diabetes was used (screening module). For 10 000 individuals with diabetes in this cohort, the model simulated the development and progression of major complications of the disease (disease progression module).

    Intervention

    People in the screening module were assigned to either 1 time opportunistic screening for diabetes or to current clinical practice. Screening was done during a routine physician visit. Diabetes was defined as a fasting plasma glucose >6.1 mmol/l (110 mg/dl) and confirmed by an oral glucose …

    View Full Text

    Footnotes

    • Source of funding: not stated.

    • For correspondence: Dr M M Engelgau, Division of Diabetes Translation, Mailstop K-10, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341–3724, USA. Fax +1 770 488 5966.